Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compound...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Published: |
Elsevier
2023
|
Online Access: | http://psasir.upm.edu.my/id/eprint/106890/ https://linkinghub.elsevier.com/retrieve/pii/S0960852423000871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.upm.eprints.106890 |
---|---|
record_format |
eprints |
spelling |
my.upm.eprints.1068902024-08-08T02:43:42Z http://psasir.upm.edu.my/id/eprint/106890/ Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review Tengku Ibrahim, Tengku Nilam Baizura Feisal, Nur Azalina Suzianti Kamaludin, Noor Haziqah Cheah, Wai Yan How, Vivien Bhatnagar, Amit Ma, Zengling Show, Pau Loke Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compounds such as -carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as “glucan, are prominent. Microalgae species that are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive), and many more. In this present review, microalgae species that are feasible in metabolite production are summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries are comprehensively discussed. This evaluation is greatly assisting industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and moving the production of microalgae-based metabolites forward. Elsevier 2023 Article PeerReviewed Tengku Ibrahim, Tengku Nilam Baizura and Feisal, Nur Azalina Suzianti and Kamaludin, Noor Haziqah and Cheah, Wai Yan and How, Vivien and Bhatnagar, Amit and Ma, Zengling and Show, Pau Loke (2023) Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review. Bioresource Technology, 372. pp. 1-14. ISSN 0960-8524; ESSN: 1873-2976 https://linkinghub.elsevier.com/retrieve/pii/S0960852423000871 10.1016/j.biortech.2023.128661 |
institution |
Universiti Putra Malaysia |
building |
UPM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Putra Malaysia |
content_source |
UPM Institutional Repository |
url_provider |
http://psasir.upm.edu.my/ |
description |
Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compounds such as -carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as “glucan, are prominent. Microalgae species that are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive), and many more. In this present review, microalgae species that are feasible in metabolite production are summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries are comprehensively discussed. This evaluation is greatly assisting industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and moving the production of microalgae-based metabolites forward. |
format |
Article |
author |
Tengku Ibrahim, Tengku Nilam Baizura Feisal, Nur Azalina Suzianti Kamaludin, Noor Haziqah Cheah, Wai Yan How, Vivien Bhatnagar, Amit Ma, Zengling Show, Pau Loke |
spellingShingle |
Tengku Ibrahim, Tengku Nilam Baizura Feisal, Nur Azalina Suzianti Kamaludin, Noor Haziqah Cheah, Wai Yan How, Vivien Bhatnagar, Amit Ma, Zengling Show, Pau Loke Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
author_facet |
Tengku Ibrahim, Tengku Nilam Baizura Feisal, Nur Azalina Suzianti Kamaludin, Noor Haziqah Cheah, Wai Yan How, Vivien Bhatnagar, Amit Ma, Zengling Show, Pau Loke |
author_sort |
Tengku Ibrahim, Tengku Nilam Baizura |
title |
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
title_short |
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
title_full |
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
title_fullStr |
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
title_full_unstemmed |
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
title_sort |
biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review |
publisher |
Elsevier |
publishDate |
2023 |
url |
http://psasir.upm.edu.my/id/eprint/106890/ https://linkinghub.elsevier.com/retrieve/pii/S0960852423000871 |
_version_ |
1807051121925029888 |
score |
13.18916 |